Leading the nation’s cancer advancements through research

Massey's nationally recognized research programs comprises nearly 150 research members discovering and developing a future without cancer.

Explore our programs

One of the Nation’s leading cancer research centers

VCU Massey Comprehensive Cancer Center is proud to be your local National Cancer institute (NCI)-designated Comprehensive Cancer Center. As one of just two centers in Virginia with this distinction, Massey is at the forefront of the nation’s cancer research efforts. Massey has been designated by the NCI since 1975 and received comprehensive status in 2023.

Learn more about Massey's quest for comprehensive designation

Preeminent research programs

Massey research members conduct cutting-edge research and lead collaborative initiatives through one of three scientific research programs.

Cancer Biology

Unraveling the causes of the growth and spread of cancer and identifying key interactions between tumors and their microenvironment

Developmental Therapeutics

Discovering, developing and evaluating novel, small molecules and biologics through clinical trials

Cancer Prevention & Control

Advancing cancer risk identification and mitigation as well as improved approaches to survivorship

Research events

Research events

Massey sponsors a range of research events for trainees and researchers.

Intramural funding

Intramural funding

Explore intramural funding opportunities for novel cancer-related research concepts.

Shared resources

Shared resources

Shared resources support the extensive cancer research portfolio of Massey scientists.

Related news

View all news

Research & Innovation

Genetic code deploys cancer mafia, new targeted drug gives them an offer they can’t refuse

Sep 3, 2025

A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biological turf war by invading healthy organs and overpowering the normal cells. ...

Research & Innovation

Researchers awarded $7.3 million grant to launch groundbreaking breast cancer clinical trial

Aug 28, 2025

Venkata Lokesh Battula, Ph.D., assistant director of Massey’s Cancer Research Training and Education Coordination Efforts (CRTEC) and professor in the Department of Internal Medicine at the VCU School of Medicine, identified GD2 as a new marker in triple-negative breast cancer patients....